In the pharmaceutical industry, new modalities such as mRNA vaccines and an increasing number of biosimilars in biologics, help make critical therapies available to more patients in need, but they also put pressure on manufacturers to deliver these therapies safely and cost-effectively. While there is not a single solution to increasing operational efficiency and minimizing costs of non-quality, automating the quality control testing process can help to:
- Reduce costly errors
- Provide reliable, actionable, and traceable data
- Deliver rapid results
- Increase throughput to reduce bottlenecks
By leveraging automation, digitalization, and decentralized testing, automated technologies for in-process and release testing improve operational efficiency while reducing production costs through lower non-quality costs and optimized working capital.
bioMérieux offers automation solutions at key control points:
Environmental Monitoring:
3P® ENTERPRISE: fully digitalized environmental monitoring solution. Combined with VITEK® MS PRIME (MALDI-TOF) for robust identification.
Mycoplasma Testing:
BIOFIRE® SPOTFIRE®: only 2 minutes of hands-on time, with results in less than 1 hour. Can be performed by anyone, anywhere, at any time.< /p>
Sterility Testing:
BACT/ALERT® 3D: simplifies sterility testing of complex matrices. Automated monitoring with real-time contamination alerts.
Endotoxin Testing:
ENDOZYME® II GO: reduces errors, hands-on time and variability. Flexible throughput from single-sample testing to full automation.
